Stryker Corp. (SYK) scored on five pillars from its reported financial statements, and ranked against 212 Healthcare companies.
Stryker Corp. (SYK) scores 7.0 out of 10 as of , computed from its reported financial statements. That reads as high quality. The reading rests on predictability, and profitability is what holds it back.
Data provided by Twelve Data. Scores are computed by Lemma Analysis from reported financials.
We cannot judge Stryker Corp. yet, because fewer than five years had both a return on capital and a cost of capital we could measure. This is not a “no”.
Quantitative signs of a moat, read from the filed statements. This is not a judgement of where it comes from (brand, network effects, switching costs). How Lemma measures a moat →
The Quality Score for SYK stands at 7.0 out of 10 as of October 19, 2026, which puts Stryker Corp. in the high quality band. Businesses in this band tend to combine good returns with a sound balance sheet, even if one pillar lags the others. It rolls Stryker Corp.’s profitability, solvency, growth, efficiency and predictability into one number, each judged against the norms of its sector.
Ranked with the 212 Healthcare companies Lemma publishes, the score sits at the 90th percentile, among the top tenth of the group. For reference, the middle of the group scores 4.4 and a company needs 6.0 to reach its top quarter, which leaves Stryker Corp. well above the median.
Stryker Corp.’s profitability score is 5.9 out of 10 (average). Against a median of 2.7 among 210 Healthcare companies, that is well above the group and the 78th percentile. Profitability in the middle of the range is neither a moat nor a warning: margins and returns look like those of an ordinary business in this line of work.
On solvency, Stryker Corp. scores 7.5, a strong reading. Its peers have a median of 6.5 across 150 Healthcare companies, which places it above them, at the 61st percentile. Balance sheet strength like this rarely makes headlines, but it is what lets a company keep investing when credit gets expensive.
Stryker Corp.’s growth score is 6.7 out of 10 (average). Against a median of 4.9 among 107 Healthcare companies, that is well above the group and the 72nd percentile. Growth near the median is neither a reason to buy nor a concern, but it does mean the quality case rests more on the other pillars.
On efficiency, Stryker Corp. scores 7.3, a strong reading. Its peers have a median of 6.0 across 200 Healthcare companies, which places it above them, at the 69th percentile. A strong efficiency reading usually shows up as healthy cash conversion: reported profit arriving as real cash rather than staying on the balance sheet.
On predictability, Stryker Corp. scores 7.9, a strong reading. Its peers have a median of 3.4 across 207 Healthcare companies, which places it well above them, at the 95th percentile. High predictability means the company’s results have moved steadily from year to year, which makes the other pillars more trustworthy as a guide.
Predictability at 7.9 is Stryker Corp.’s best pillar and profitability at 5.9 its weakest. The 2.0 point gap between them is worth keeping in mind when reading the overall. Leading with predictability suits a steady compounder, even if the other pillars are less striking. Weak profitability can be cyclical, so it helps to know whether margins are at a low point or a long-run level.
Stryker Corp. has no pillar below the median of Healthcare companies, which leaves little room to rise. Its exposure is to slippage instead, and profitability carries the most weight: one point less there would mean an overall of roughly 6.8 rather than 7.0. The weights add up to 100 points (profitability 25, solvency 20, growth 20, efficiency 15, predictability 20), and Stryker Corp. has a reading on every pillar.
For a fair comparison, start with companies of a similar size: the Healthcare companies below are nearest to Stryker Corp. by market value, each scored on the same pillars.
How much profit the company generates from its capital and sales.
The company’s ability to service debt and meet its obligations.
How fast revenue, earnings and cash flow are compounding.
How well assets and earnings convert into cash and output.
How stable and consistent results have been over time.
Each metric is scored from 0 to 10 against sector-aware benchmarks, where higher is better. Metrics roll up into five pillars, and the pillars combine into the overall score using the weights shown. Sector-sensitive metrics are judged relative to peers in the same sector.
This score is a systematic, backward-looking read of reported fundamentals. It does not judge valuation, management quality, competitive moat, or future prospects, and can be distorted by one-off items or unusual accounting. Treat it as a starting point, not a recommendation.
Educational only. Not investment advice.
On this reading Stryker Corp. scores 7.0 out of 10, which reads as high quality. Its strongest pillar is predictability, its weakest is profitability. Quality is not the same as a good investment: the score says nothing about the price you would pay.
Stryker Corp. ranks at the 90th percentile of the 212 Healthcare companies Lemma publishes a score for. The median there is 4.4 and the top quarter starts at 6.0, against Stryker Corp.’s 7.0.
Five pillars, each scored from 0 to 10 against sector-aware benchmarks and then weighted into one overall reading: profitability, solvency, growth, efficiency and predictability. Everything comes from reported financials, and nothing comes from price, sentiment or forecasts.
This page last changed on October 19, 2026. The score moves with the financial statements, so the page changes when a new filing moves the reading rather than on a schedule. Live figures for SYK are in the app.
No. Quality and valuation are separate questions, and a good business at the wrong price is still a bad purchase. Score the business here, then price it with a DCF you control.
Inside Lemma Analysis the same five pillars run on every company we cover, with the metrics behind each one, current fundamentals, a DCF you control and a watchlist that tells you when the price catches up.
Free to start · No credit card